Who owns ATHIRA PHARMA INC?
- Ticker: ATHA
- CUSIP Number: 04746l104
Tip: Access positions for across all investors
Analyze quarterly positions in Athira Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Athira Pharma stock
Who bought or sold ATHIRA PHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Perceptive Advisors | 5.4M | $13M | 13% | Dec 2023 |
|
Baker Bros. Advisors | 3.2M | $7.7M | 0% | Dec 2023 |
|
Vanguard Group | 1.7M | $4.1M | 0% | Dec 2023 |
|
Simplify Asset Management | 1.5M | $3.6M | 0% | Dec 2023 |
|
Propel Bio Management | 1.5M | $3.6M | 100% | Dec 2023 |
|
BML Capital Management | 1.5M | $3.5M | -15% | Dec 2023 |
|
Tang Capital Management | 1.2M | $2.8M | 227% | Dec 2023 |
|
BlackRock | 663k | $1.3M | -1% | Sep 2023 |
|
Millennium Management | 456k | $1.1M | -39% | Dec 2023 |
|
Pathstone Family Office | 426k | $860k | 0% | Sep 2023 |
|
Pathstone Holdings | 372k | $905k | 100% | Dec 2023 |
|
Citadel Advisors | 366k | $890k | -3% | Dec 2023 |
|
Dimensional Fund Advisors | 347k | $843k | -35% | Dec 2023 |
|
Two Sigma Investments | 304k | $739k | 14% | Dec 2023 |
|
GSA Capital Partners | 301k | $731k | 1% | Dec 2023 |
|
Two Sigma Advisers | 299k | $726k | 7% | Dec 2023 |
|
Geode Capital Management | 283k | $573k | -3% | Sep 2023 |
|
Renaissance Technologies | 283k | $571k | -36% | Sep 2023 |
|
Jacobs Levy Equity Management | 270k | $657k | -10% | Dec 2023 |
|
Bridgeway Capital Management | 186k | $375k | 29% | Sep 2023 |
|
Nan Fung Group Holdings | 180k | $364k | 1429% | Sep 2023 |
|
Laird Norton Tyee Trust | 179k | $361k | 21% | Sep 2023 |
|
Barclays | 174k | $440k | -60% | Dec 2023 |
|
Advisor Group Holdings | 170k | $413k | 20% | Dec 2023 |
|
Potomac Capital Management | 150k | $364k | 101% | Dec 2023 |
|
Acadian Asset Management | 140k | $281k | -43% | Sep 2023 |
|
State Street Corporation | 108k | $218k | -9% | Sep 2023 |
|
Verition Fund Management | 100k | $202k | -10% | Sep 2023 |
|
Susquehanna International | 94k | $189k | -19% | Sep 2023 |
|
Bristlecone Advisors | 85k | $207k | 0% | Dec 2023 |
|
CornerCap Investment Counsel | 75k | $183k | 0% | Dec 2023 |
|
Morgan Stanley | 62k | $125k | -46% | Sep 2023 |
|
Northern Trust | 55k | $110k | -5% | Sep 2023 |
|
Clarius | 54k | $130k | 36% | Dec 2023 |
|
Bank of America Corporation | 49k | $118k | -89% | Dec 2023 |
|
William Blair $ Company | 36k | $88k | 0% | Dec 2023 |
|
Royal Bank of Canada | 36k | $92k | 1740% | Dec 2023 |
|
Rothschild Investment Corp | 34k | $68k | 0% | Sep 2023 |
|
Levin Easterly Partners | 34k | $81k | 0% | Dec 2023 |
|
Integrity Financial Corp | 33k | $80k | 0% | Dec 2023 |
|
Springbok Capital Management | 32k | $65k | 11% | Sep 2023 |
|
Jane Street | 23k | $55k | 100% | Dec 2023 |
|
Forefront Analytics | 21k | $42k | 0% | Sep 2023 |
|
Massey, Quick & Co | 21k | $50k | 0% | Dec 2023 |
|
Journey Strategic Wealth | 21k | $50k | 0% | Dec 2023 |
|
Sargent Investment Group | 18k | $44k | -12% | Dec 2023 |
|
Cubist Systematic Strategies | 17k | $41k | -14% | Dec 2023 |
|
Bank of New York Mellon | 16k | $39k | 0% | Dec 2023 |
|
Occudo Quantitative Strategies | 16k | $38k | -26% | Dec 2023 |
|
Ameriprise Financial | 15k | $31k | 0% | Sep 2023 |
|
American Century Companies | 15k | $31k | 100% | Sep 2023 |
|
Federated Investors | 14k | $34k | -6% | Dec 2023 |
|
Private Advisor | 13k | $32k | 100% | Dec 2023 |
|
HighTower Advisors | 13k | $30k | -1% | Dec 2023 |
|
Lindbrook Capital | 9.7k | $24k | 0% | Dec 2023 |
|
Qube Research & Technologies | 4.7k | $9.4k | -92% | Sep 2023 |
|
Point72 Asia | 3.1k | $7.5k | 100% | Dec 2023 |
|
Rhumbline Advisers | 1.5k | $3.7k | 0% | Dec 2023 |
|
FMR | 1.0k | $2.0k | -67% | Sep 2023 |
|
UBS Group | 932.00 | $2.3k | -99% | Dec 2023 |
|
McIlrath & Eck | 825.00 | $2.0k | 0% | Dec 2023 |
|
Wells Fargo & Company | 234.00 | $568.994400 | -98% | Dec 2023 |
|
Tower Research Capital | 162.00 | $326.997000 | 100% | Sep 2023 |
|
Householder Group Estate & Retirement Specialist | 150.00 | $0 | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 143.00 | $347.003800 | -86% | Dec 2023 |
|
Citigroup | 75.00 | $182.002500 | 0% | Dec 2023 |
|
Who sold out of Athira Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Point72 Asset Management | Sep 2023 | 908k | $1.8M |
Acuitas Investments | Sep 2023 | 150k | $302k |
Old Mission Capital | Jun 2023 | 81k | $240k |
Y-Intercept | Jun 2023 | 37k | $110k |
Ergoteles | Jun 2023 | 34k | $99k |
Brighton Jones | Sep 2023 | 32k | $65k |
Marquette Asset Management | Sep 2023 | 31k | $62k |
D. E. Shaw & Co | Sep 2023 | 30k | $61k |
Algert Coldiron Investors | Sep 2023 | 28k | $56k |
Squarepoint Ops | Sep 2023 | 11k | $22k |
Ohio Pers | Sep 2023 | 9.2k | $19k |
Quantbot Technologies | Jun 2023 | 1.6k | $4.7k |
Pnc Financial Services | Sep 2023 | 1.5k | $3.0k |